FR3110582B1 - Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations. - Google Patents

Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations. Download PDF

Info

Publication number
FR3110582B1
FR3110582B1 FR2005382A FR2005382A FR3110582B1 FR 3110582 B1 FR3110582 B1 FR 3110582B1 FR 2005382 A FR2005382 A FR 2005382A FR 2005382 A FR2005382 A FR 2005382A FR 3110582 B1 FR3110582 B1 FR 3110582B1
Authority
FR
France
Prior art keywords
biomaterial
elastomeric matrix
sulphated polysaccharide
polysaccharide
reconstruction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2005382A
Other languages
English (en)
Other versions
FR3110582A1 (fr
Inventor
Didier Lutomski
Géraldine Rohman
Sylvie Changotade
Karim Senni
Carole Chakar
Wassim Manhal
Ronald Younes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Univ Paris Xiii Paris Nord Villetaneuse Fr
UNIVERSITE ST-JOSEPH DE BEYROUTH, LB
Centre National de la Recherche Scientifique CNRS
Universite Paris Cite
Original Assignee
Centre National de la Recherche Scientifique CNRS
Universite Sorbonne Paris Nord Paris 13
Universite de Paris
Univ St Joseph De Beyrouth
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centre National de la Recherche Scientifique CNRS, Universite Sorbonne Paris Nord Paris 13, Universite de Paris, Univ St Joseph De Beyrouth filed Critical Centre National de la Recherche Scientifique CNRS
Priority to FR2005382A priority Critical patent/FR3110582B1/fr
Priority to EP21726418.3A priority patent/EP4153651A1/fr
Priority to CN202080101135.0A priority patent/CN115803356A/zh
Priority to US17/997,433 priority patent/US20230263937A1/en
Priority to JP2022571177A priority patent/JP2023526504A/ja
Priority to PCT/EP2021/063472 priority patent/WO2021234088A1/fr
Publication of FR3110582A1 publication Critical patent/FR3110582A1/fr
Application granted granted Critical
Publication of FR3110582B1 publication Critical patent/FR3110582B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/26—Mixtures of macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
    • C08G18/72—Polyisocyanates or polyisothiocyanates
    • C08G18/73—Polyisocyanates or polyisothiocyanates acyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/08—Processes
    • C08G18/16—Catalysts
    • C08G18/22—Catalysts containing metal compounds
    • C08G18/24—Catalysts containing metal compounds of tin
    • C08G18/244—Catalysts containing metal compounds of tin tin salts of carboxylic acids
    • C08G18/246—Catalysts containing metal compounds of tin tin salts of carboxylic acids containing also tin-carbon bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G18/00—Polymeric products of isocyanates or isothiocyanates
    • C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
    • C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
    • C08G18/40—High-molecular-weight compounds
    • C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
    • C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
    • C08G18/4269—Lactones
    • C08G18/4277—Caprolactone and/or substituted caprolactone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/34—Materials or treatment for tissue regeneration for soft tissue reconstruction

Abstract

« Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations. » La présente invention concerne un biomatériau comprenant au moins une matrice élastomère et un polysaccharide, et ses utilisations dans le renforcement, la reconstruction et/ou du comblement des défauts tissulaires, de préférence le renforcement, la reconstruction et/ou du comblement des défauts des tissus mous et/ou les tissus épithéliaux, de préférence la réparation de la peau et/ou des muqueuses.
FR2005382A 2020-05-20 2020-05-20 Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations. Active FR3110582B1 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
FR2005382A FR3110582B1 (fr) 2020-05-20 2020-05-20 Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations.
EP21726418.3A EP4153651A1 (fr) 2020-05-20 2021-05-20 Biomateriau comprenant au moins une matrice elastomere et un polysaccharide non sulfate et ses utilisations
CN202080101135.0A CN115803356A (zh) 2020-05-20 2021-05-20 包括至少一种弹性体基质和非硫酸化多糖的生物材料及其用途
US17/997,433 US20230263937A1 (en) 2020-05-20 2021-05-20 Biomaterial comprising at least one elastomeric matrix and a non-sulfated polysaccharide and uses thereof
JP2022571177A JP2023526504A (ja) 2020-05-20 2021-05-20 少なくとも１つのエラストマーマトリックスおよび非硫酸化多糖を含む生体材料およびその使用
PCT/EP2021/063472 WO2021234088A1 (fr) 2020-05-20 2021-05-20 Biomateriau comprenant au moins une matrice elastomere et un polysaccharide non sulfate et ses utilisations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2005382A FR3110582B1 (fr) 2020-05-20 2020-05-20 Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations.
FR2005382 2020-05-20

Publications (2)

Publication Number Publication Date
FR3110582A1 FR3110582A1 (fr) 2021-11-26
FR3110582B1 true FR3110582B1 (fr) 2023-04-14

Family

ID=72178756

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2005382A Active FR3110582B1 (fr) 2020-05-20 2020-05-20 Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations.

Country Status (6)

Country Link
US (1) US20230263937A1 (fr)
EP (1) EP4153651A1 (fr)
JP (1) JP2023526504A (fr)
CN (1) CN115803356A (fr)
FR (1) FR3110582B1 (fr)
WO (1) WO2021234088A1 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012097381A1 (fr) * 2011-01-14 2012-07-19 Biomerix Corporation Éléments matriciels élastomères réticulés au moins partiellement résorbables et leurs procédés de fabrication
CN108034225B (zh) * 2017-12-25 2020-07-10 武汉市工程科学技术研究院 一种制备壳聚糖/热塑性聚氨酯弹性体复合材料的方法

Also Published As

Publication number Publication date
WO2021234088A1 (fr) 2021-11-25
EP4153651A1 (fr) 2023-03-29
FR3110582A1 (fr) 2021-11-26
JP2023526504A (ja) 2023-06-21
CN115803356A (zh) 2023-03-14
US20230263937A1 (en) 2023-08-24

Similar Documents

Publication Publication Date Title
CY1119743T1 (el) Στοχοθετημενοι συνδετικοι παραγοντες εναντι β7-η1
PE20050339A1 (es) Anticuerpos humanos modificados anti-igf-1r
MXPA05001602A (es) Dispositivo de colageno y metodo para preparar el mismo.
TNSN07401A1 (fr) Anticorps diriges contre le peptide amyloide-beta, et methodes pour leurs utilisations
BRPI0510477A (pt) composições e sistemas para a formação de biomateriais reticulados e métodos associados de preparação e uso
ATE532471T1 (de) Zwischenfortsatz-implantat als abstandshalter
Mavrilas et al. Dynamic mechanical characteristics of intact and structurally modified bovine pericardial tissues
WO2009120513A3 (fr) Implants à composants multiples malléables et matériaux associés
PE20070123A1 (es) Composicion inmunogenica
BRPI0720183A2 (pt) Produto para tratamento bucal, método de remineralização e/ou branqueamento, produto que compreende uma primeira composição em combinação com uma segunda composição e uso
BR112014026090A8 (pt) composição de matriz tecidual apta a fluir
BRPI0500052A (pt) Método / sistema para acabar um poço com junta de transição selada de poço ramal
FR3110582B1 (fr) Biomatériau comprenant au moins une matrice élastomère et un polysaccharide non sulfaté et ses utilisations.
BRPI0604536A (pt) terminal móvel e método para mudar o modo do mesmo
CR20200229A (es) Variantes e isoformas de anticuerpos con actividad biológica reducida
Vidal et al. Role of proteoglycans on the biochemical and biomechanical properties of dentin organic matrix
BR112021019950A2 (pt) Métodos de esgotamento de agentes causadores de doenças por meio de anticorpo de fagocitose alvejada
EP2081029A3 (fr) Bio-marqueurs pour le diagnostic de rétinopathie diabétique
CL2023001600A1 (es) Biomarcadores del agonista de trem2 y métodos para su uso
BRPI0206904B8 (pt) métodos de quantificação de proteína glicada em uma amostra, de quantificação da quantidade de proteína glicada em uma amostra biológica, de quantificação da hemoglobina glicada em uma amostra de sangue, e de quantificação de proteína glicada que não é hemoglobina em uma amostra biológica
DE602006003903D1 (de) In-vitro-diagnoseverfahren und kit für eine schwarzschimmel-infektion
BR112022025845A2 (pt) Composição biocompatível, preenchimento de tecidos e método de tratamento ou prevenção de um distúrbio, doença ou condição
PT115407A (pt) Estrutura protésica biofuncionalizada com arquitetura de núcleo-invólucro para reparação total ou parcial de tendões ou ligamentos humanos
GT200600449A (es) Compuestos de tetrahidro-pirrolizinona farmacéuticamente activos
FR3034308A1 (fr) Implant ophtalmologique d'interposition

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20211126

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

CD Change of name or company name

Owner name: UNIVERSITE ST-JOSEPH DE BEYROUTH, LB

Effective date: 20230330

Owner name: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, FR

Effective date: 20230330

Owner name: UNIV PARIS XIII PARIS-NORD VILLETANEUSE, FR

Effective date: 20230330

Owner name: UNIVERSITE PARIS CITE, FR

Effective date: 20230330